Index of reports
> Cases with Dizziness (6)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Medroxyprogesterone where reactions include dizziness. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Medroxyprogesterone side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-27
Patient: female, weighing 65.8 kg (144.7 pounds)
Reactions: Migraine, Agitation, Drug Ineffective, Nausea, Disorientation, Stress, Gastric Disorder, Somnolence, Tremor, Irritability, DRY Mouth, Dizziness, Memory Impairment, Nervousness
Drug(s) suspected as cause:
Spiriva
Indication: Asthma
Combivent
Indication: Asthma
Trazodone Hydrochloride
Norvasc
Indication: Hypertension
Advair HFA
Indication: Asthma
Symbicort
Indication: Bronchitis
Unspecified Nebulizer
Indication: Bronchitis
Seroquel
Indication: Bipolar I Disorder
Advair HFA
Indication: Bronchitis
Symbicort
Indication: Emphysema
Unspecified Nebulizer
Indication: Emphysema
Inderal
Niaspan
Dosage: 500 mg
Indication: Blood Cholesterol Increased
Spiriva
Indication: Emphysema
Seroquel
Dosage: 100 mg
Indication: Postpartum Stress Disorder
Start date: 2006-01-01
Combivent
Indication: Emphysema
Geodon
Aspirin
Dosage: 81 mg
Lisinopril
Dosage: 40 mg
Indication: Hypertension
Unspecified Nebulizer
Indication: Asthma
Unspecified Patch
Spiriva
Indication: Bronchitis
Chantix
Medroxyprogesterone
Coreg
Dosage: 25 mg
Advair HFA
Indication: Emphysema
Symbicort
Indication: Asthma
Combivent
Indication: Bronchitis
Depakote
Estradiol
Chantix
Dosage: 0.5 mg
Administration route: Oral
Indication: Smoking Cessation Therapy
Start date: 2012-02-01
Possible Medroxyprogesterone side effects in 50 year old female
Reported by a consumer/non-health professional from United States on 2012-03-23
Patient: 50 year old female, weighing 65.8 kg (144.8 pounds)
Reactions: Agitation, Migraine, Nausea, Disorientation, Somnolence, Stress, Gastric Disorder, Irritability, DRY Mouth, Dizziness, Memory Impairment, Nervousness
Drug(s) suspected as cause:
Estradiol
Spiriva
Indication: Asthma
Advair Diskus 100 / 50
Indication: Asthma
Unspecified Nebulizer
Indication: Emphysema
Symbicort
Dosage: unknown frequency
Indication: Bronchitis
Symbicort
Dosage: unknown frequency
Indication: Emphysema
Spiriva
Indication: Bronchitis
Unspecified Nebulizer
Indication: Asthma
Unspecified Patch
Norvasc
Indication: Hypertension
Advair Diskus 100 / 50
Indication: Bronchitis
Unspecified Nebulizer
Indication: Bronchitis
Chantix
Indication: Emphysema
Seroquel
Administration route: Oral
Indication: Bipolar I Disorder
Start date: 2006-01-01
Trazodone HCL
Combivent
Symbicort
Dosage: unknown frequency
Indication: Asthma
Lisinopril
Administration route: Oral
Indication: Hypertension
Depakote
Niaspan
Indication: Hypercholesterolaemia
Spiriva
Indication: Emphysema
Seroquel
Administration route: Oral
Indication: Postpartum Stress Disorder
Start date: 2006-01-01
Aspirin
Coreg
Medroxyprogesterone
Inderal
Geodon
Advair Diskus 100 / 50
Indication: Emphysema
Chantix
Indication: Asthma
Chantix
Indication: Bronchitis
Possible Medroxyprogesterone side effects in female
Reported by a consumer/non-health professional from United States on 2012-03-06
Patient: female, weighing 65.8 kg (144.7 pounds)
Reactions: Agitation, Migraine, Nausea, Drug Ineffective, Disorientation, Gastric Disorder, Stress, Somnolence, Tremor, Irritability, DRY Mouth, Dizziness, Memory Impairment, Nervousness
Drug(s) suspected as cause:
Geodon
Trazodone Hydrochloride
Symbicort
Indication: Asthma
Divalproex Sodium
Chantix
Dosage: 0.5 mg
Administration route: Oral
Indication: Smoking Cessation Therapy
Start date: 2012-02-01
Norvasc
Indication: Hypertension
Niaspan
Dosage: 500 mg
Indication: Blood Cholesterol Increased
Advair HFA
Indication: Bronchitis
Unspecified Nebulizer
Indication: Emphysema
Spiriva
Indication: Bronchitis
Combivent
Indication: Asthma
Coreg
Dosage: 25 mg
Combivent
Indication: Bronchitis
Aspirin
Dosage: 81 mg
Advair HFA
Indication: Asthma
Spiriva
Indication: Asthma
Spiriva
Indication: Emphysema
Lisinopril
Dosage: 40 mg
Indication: Hypertension
Medroxyprogesterone
Seroquel
Dosage: 100 mg
Indication: Postpartum Stress Disorder
Start date: 2006-01-01
Symbicort
Indication: Emphysema
Combivent
Indication: Emphysema
Chantix
Inderal
Seroquel
Indication: Bipolar I Disorder
Advair HFA
Indication: Emphysema
Symbicort
Indication: Bronchitis
Unspecified Nebulizer
Indication: Bronchitis
Estradiol
Unspecified Nebulizer
Indication: Asthma
Unspecified Patch
Possible Medroxyprogesterone side effects in female
Reported by a consumer/non-health professional from United States on 2012-02-27
Patient: female, weighing 65.0 kg (143.0 pounds)
Reactions: Agitation, Migraine, Nausea, Drug Ineffective, Disorientation, Gastric Disorder, Somnolence, Stress, Tremor, Irritability, DRY Mouth, Dizziness, Memory Impairment, Nervousness
Drug(s) suspected as cause:
Inderal
Dosage: unk
Lisinopril
Dosage: 40 mg, daily
Indication: Hypertension
Medroxyprogesterone
Dosage: 2.5 mg, unk
Coreg
Dosage: 12.5 mg, 2x/day
Spiriva
Indication: Emphysema
Estradiol
Dosage: 0.5 mg, unk
Advair Diskus 100 / 50
Indication: Emphysema
Advair Diskus 100 / 50
Dosage: unk
Indication: Asthma
Advair Diskus 100 / 50
Indication: Bronchitis
Symbicort
Indication: Bronchitis
Norvasc
Dosage: 10 mg, unk
Indication: Hypertension
Acetylsalicylic Acid SRT
Dosage: 81 mg, daily
Seroquel
Dosage: 100 mg, daily
Indication: Postpartum Disorder
Start date: 2006-01-01
Chantix
Dosage: 0.5 mg daily
Administration route: Oral
Indication: Smoking Cessation Therapy
Start date: 2012-02-01
Chantix
Dosage: unk
Administration route: Oral
Geodon
Dosage: unk
Spiriva
Indication: Bronchitis
Trazodone HCL
Dosage: unk
Combivent
Indication: Emphysema
Spiriva
Dosage: unk
Indication: Asthma
Seroquel
Indication: Bipolar I Disorder
Niaspan
Dosage: 500 mg, daily
Indication: Blood Cholesterol Increased
Combivent
Indication: Bronchitis
Depakote
Dosage: unk
Symbicort
Dosage: unk
Indication: Asthma
Symbicort
Indication: Emphysema
Combivent
Dosage: unk
Indication: Asthma
Possible Medroxyprogesterone side effects in female
Reported by a physician from United States on 2011-12-01
Patient: female, weighing 68.0 kg (149.6 pounds)
Reactions: Foot Deformity, Abdominal Pain, Endometrial Hyperplasia, Aortic Stenosis, Chronic Obstructive Pulmonary Disease, Vitamin B12 Deficiency, Dyspepsia, Uterine Leiomyoma, Breast Hyperplasia, Metabolic Disorder, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Ovarian Cyst, Coronary Artery Disease, Breast Mass, Cervical Dysplasia, Insomnia, Pelvic Pain, Fibrocystic Breast Disease, Fatigue, Chest Pain, Liver Function Test Abnormal, Dizziness, Depression, Gastrooesophageal Reflux Disease, Dyspnoea, Nausea, Amnesia, Rectocele, Dysuria, Visual Impairment
Drug(s) suspected as cause:
Premarin
Dosage: 0.625 mg, unk
Indication: Menopause
Start date: 1990-11-26
End date: 2000-11-01
Provera
Dosage: 10 mg, unk
Start date: 1990-11-26
Medroxyprogesterone
Indication: Menopause
Start date: 1991-01-01
Provera
Dosage: 2.5 mg, unk
End date: 2000-11-01
Ogen
Provera
Indication: Menopause
Start date: 1988-01-01
End date: 1991-01-01
Premarin
Start date: 1988-01-01
End date: 1991-01-01
Prempro
Provera
Start date: 1991-01-01
Premarin
Administration route: Topical
Indication: Menopause
Start date: 1992-03-11
End date: 1997-11-23
Hormones
Administration route: Topical
Indication: Menopause
Start date: 1991-01-01
Climara
Estraderm
Indication: Menopause
Start date: 1991-01-01
End date: 1993-03-11
Estraderm
Dosage: 0.05 mg, biw
Start date: 1992-03-11
End date: 1993-03-11
Cycrin
Dosage: 2.5 mg, unk
Indication: Menopause
Start date: 1997-11-17
End date: 1997-12-17
Other drugs received by patient: Calcium Carbonate; Fosamax; Plavix; Prednisone TAB; Tamoxifen Citrate; Zantac; Magnesium Sulfate; Tricor; Methotrexate; Fluconazole; Paxil; Naproxen (Aleve); Aspirin; Prevacid; Macrodantin; Folic Acid; Zoloft
Possible Medroxyprogesterone side effects in female
Reported by a lawyer from United States on 2011-11-29
Patient: female, weighing 68.0 kg (149.6 pounds)
Reactions: Abdominal Pain, Aortic Stenosis, Pelvic Pain, Chronic Obstructive Pulmonary Disease, Fatigue, Fibrocystic Breast Disease, Dyspepsia, Uterine Leiomyoma, Chest Pain, Liver Function Test Abnormal, Dizziness, Breast Hyperplasia, Depression, Arteriosclerosis, Breast Cancer, Cardiac Murmur, Hiatus Hernia, Nausea, Breast Mass, Ovarian Cyst, Cervical Dysplasia, Amnesia, Rectocele, Visual Impairment
Drug(s) suspected as cause:
Provera
Dosage: 10 mg, unk
Start date: 1990-11-26
Cycrin
Dosage: 2.5 mg, unk
Indication: Menopause
Start date: 1997-11-17
End date: 1997-12-17
Prempro
Hormones
Administration route: Topical
Indication: Menopause
Start date: 1991-01-01
Ogen
Provera
Start date: 1991-01-01
Premarin
Dosage: 0.625 mg, unk
Indication: Menopause
Start date: 1990-11-26
End date: 2000-11-01
Premarin
Administration route: Topical
Indication: Menopause
Start date: 1992-03-11
End date: 1997-11-23
Estraderm
Dosage: 0.05 mg, biw
Start date: 1992-03-11
End date: 1993-03-11
Premarin
Start date: 1988-01-01
End date: 1991-01-01
Medroxyprogesterone
Indication: Menopause
Start date: 1991-01-01
Provera
Indication: Menopause
Start date: 1988-01-01
End date: 1991-01-01
Provera
Dosage: 2.5 mg, unk
End date: 2000-11-01
Climara
Estraderm
Indication: Menopause
Start date: 1991-01-01
End date: 1993-03-11
Other drugs received by patient: Methotrexate; Aspirin; Naproxen (Aleve); Magnesium Sulfate; Plavix; Macrodantin; Tamoxifen Citrate; Zantac; Prevacid; Fluconazole; Paxil; Prednisone; Folic Acid; Zoloft; Calcium Carbonate; Fosamax; Tricor
|